June 22, 2020 / 1:50 PM / 14 days ago

BRIEF-Sutro Biopharma Presents Synergy Between Stro-002 And Immune Checkpoint At 2020 AACR Virtual Meeting

June 22 (Reuters) - Sutro Biopharma Inc:

* SUTRO BIOPHARMA PRESENTS NEW PRECLINICAL DATA AT 2020 AACR VIRTUAL ANNUAL MEETING II SUGGESTING SYNERGY BETWEEN ITS STRO-002 ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITORS RESULTING IN TUMOR REGRESSION AND ADAPTIVE ANTI-TUMOR IMMUNITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below